Back
Medifast, Inc. 10K Form
Sell
27
MED
Medifast, Inc.
Last Price:
$10.84
Seasonality Move:
9.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-29 | 10Q | MED/Medifast, Inc. Quarterly |
| 2023-11-06 | 10Q | MED/Medifast, Inc. Quarterly |
| 2023-08-07 | 10Q | MED/Medifast, Inc. Quarterly |
| 2023-05-01 | 10Q | MED/Medifast, Inc. Quarterly |
| 2022-11-03 | 10Q | MED/Medifast, Inc. Quarterly |
| 2022-08-03 | 10Q | MED/Medifast, Inc. Quarterly |
Receive MED News And Ratings
See the #1 stock for the next 7 days that we like better than MED
MED Financial Statistics
Sales & Book Value
| Annual Sales: | $602.5M |
|---|---|
| Cash Flow: | $10.8M |
| Price / Cash Flow: | 184.85 |
| Annual Sales: | $19.53 |
| Price / Book: | 0.56 |
Profitability
| EPS (TTM): | 0.02090 |
|---|---|
| Net Income (TTM): | $248K |
| Gross Margin: | $444.6M |
| Return on Equity: | 0.12% |
| Return on Assets: | 0.09% |
Medifast, Inc. Earnings Forecast
Key Medifast, Inc. Financial Ratios
-
The Gross Profit Margin over the past 29 years for MED is 73.80%.
-
The Selling, General & Administrative Expenses for MED have been equal to 73.32% of Gross Profit Margin.
-
The Research & Development expenses have been 0.76% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of MED is 0.35% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 16 years.
Medifast, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Personal Care Products |
| Sector: | Consumer Staples |
| Current Symbol: | MED |
| CUSIP: | 58470H |
| Website: | medifastinc.com |
Debt
| Debt-to-Equity Ratio: | 0.06 |
|---|---|
| Current Ratio: | 4.45 |
| Quick Ratio: | 3.71 |
Price-to-Earnings
| Trailing P/E Ratio: | 56.95 |
|---|---|
| Forward P/E Ratio: | 32.26 |
MED Technical Analysis vs Fundamental Analysis
Sell
27
Medifast, Inc. (MED)
is a Sell
Is Medifast, Inc. a Buy or a Sell?
-
Medifast, Inc. stock is rated a SellThe current Medifast, Inc. [MED] share price is $10.86. The Score for MED is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.